Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Scientific Reports|June 17, 2022
Evaluation of the association of serum glypican-4 with prevalent and future kidney functionAxel Muendlein, Eva Maria Brandtner, Andreas Leiherer, et al.
Data in Brief|May 2, 2022
Data on the association of serum glypican-4 with future major adverse cardiovascular events and mortality in patients undergoing coronary angiographyAxel Muendlein, Eva Maria Brandtner, Andreas Leiherer, et al.
Oncotarget|October 22, 2016
Nuclear FOXO3 predicts adverse clinical outcome and promotes tumor angiogenesis in neuroblastomaJudith Hagenbuchner, Martina Rupp, Christina Salvador, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2020
Serum Parathyroid Hormone Predicts Mortality in Coronary Angiography Patients with Type 2 DiabetesEva Maria Brandtner, Axel Muendlein, Andreas Leiherer, et al.
Atherosclerosis|June 27, 2025
Serum leucine-rich α-2 glycoprotein 1 predicts 10-year mortality and vascular events in coronary angiography patientsAxel Muendlein, Andreas Leiherer, Eva Maria Brandtner, et al.
Clinical Biochemistry|October 16, 2023
Circulating glypican-4 is a new predictor of all-cause mortality in patients with heart failureAxel Muendlein, Christine Heinzle, Andreas Leiherer, et al.
Molecular Cancer|September 29, 2014
C10ORF10/DEPP, a transcriptional target of FOXO3, regulates ROS-sensitivity in human neuroblastomaStefan Salcher, Judith Hagenbuchner, Kathrin Geiger, et al.
European Journal of Clinical Investigation|June 2, 2026
Circulating Human Epididymis Protein 4 Predicts 10-Year Mortality and Major Adverse Cardiovascular Events in Patients With Peripheral Artery DiseaseAxel Muendlein, Christine Heinzle, Kathrin Geiger, et al.
Kidney360|March 10, 2025
Evaluation of Circulating GPC4 in Patients with End-Stage Kidney DiseaseAxel Muendlein, Eva Maria Brandtner, Judith Schimpf, et al.
Scientific Reports|March 25, 2021
Significant impact of circulating tumour DNA mutations on survival in metastatic breast cancer patientsAxel Muendlein, Kathrin Geiger, Stella Gaenger, et al.
Pageof 6